Press Release Archive

The information in these news pages is accurate or current only as of the date of the particular press release or posting. Gilead does not update press releases once they have been made public. Press releases may contain forward-looking statements. Actual results could vary dramatically as a result of known and unknown risks and uncertainties.

February 2, 2012
Gilead Sciences Announces Fourth Quarter and Full Year 2011 Financial Results

January 26, 2012
Gilead Sciences to Release Fourth Quarter and Year End 2011 Financial Results on Thursday, February 2, 2012

January 24, 2012
Gilead Initiates Phase 2 Clinical Trial Evaluating GS-7340, A Low-Dose Novel Prodrug of Tenofovir for the Treatment of HIV

January 18, 2012
U.S. Food and Drug Administration Approves New Formulations of Viread® for Use by Children Living With HIV

January 18, 2012
Roy D. Baynes, MD, PhD, to Join Gilead Sciences as Senior Vice President, Oncology Therapeutics